Phase I trial of volasertib, a Polo-like kinase inhibitor, plus platinum agents in solid tumors: safety, pharmacokinetics and activity

Overview of attention for article published in Investigational New Drugs, March 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 6 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 2 additional patents.